<ѻý>Plaque Psoriasis Drug Shows Promise for Psoriatic Arthritisѻý> Monoclonal antibody targets the IL-23 p19 subunit May 20, 2021
<ѻý>For Safety, One Biologic a Winner in Psoriasis, Psoriatic Arthritisѻý> Lower hospitalization rates compared with other biologics or small molecule therapies May 19, 2021
<ѻý>Stopping IL-17 Drug for Axial Spondyloarthritis? Expect Spinal Flaresѻý> But low disease activity regained if treatment restarted May 11, 2021
<ѻý>The Death of One Little Girl Helped Millionsѻý> A case more than 35 years ago has spurred discoveries ever since May 07, 2021 podcast
<ѻý>Results Disappoint for Fecal Transplant in Arthritisѻý> But interest persists in targeting the gut-joint axis in psoriatic arthritis May 04, 2021
<ѻý>Pegloticase Safe for Dialysis Patients With Goutѻý> Significant drop in monthly ESA dose seen after treatment, too Apr 09, 2021
<ѻý>For Enthesitis in Psoriatic Arthritis, Target IL-23ѻý> Targeted agent provides relief for many PsA patients Apr 08, 2021
<ѻý>JAK Inhibitor Promising in Psoriatic Arthritisѻý> Oral agent noninferior to adalimumab in joint symptoms Apr 01, 2021
<ѻý>FDA Panel Unhappy With Novel OA Pain Drugѻý> Latest setback for troubled osteoarthritis biologic Mar 25, 2021
<ѻý>Don't Stop Taltz in Psoriatic Arthritisѻý> Significantly more patients relapsed, and more quickly, after withdrawal Mar 10, 2021
<ѻý>JAK Inhibitor a Hit With RA Patientsѻý> Superior to adalimumab on many patient-reported outcomes Feb 26, 2021
<ѻý>JAK Inhibitor Misses Endpoint in Safety Study. Now What?ѻý> Major blow to popular class of oral rheumatology drugs Jan 27, 2021
<ѻý>PET Scans Reveal Vascular Inflammationѻý> In giant cell arteritis, imaging confirmed clinical response Jan 07, 2021
<ѻý>Spinal Benefits Seen With Cosentyx in PsAѻý> First trial to evaluate response of axial symptoms in psoriatic arthritis to biologic treatment Dec 22, 2020
<ѻý>TYK2 Inhibition Promising in Psoriatic Arthritisѻý> Phase II study found significant benefits for two doses of novel agent Nov 10, 2020
<ѻý>COVID Complications Common with Rheumatic Diseaseѻý> Adverse outcomes included acute kidney injury and congestive heart failure Nov 08, 2020
<ѻý>Rinvoq for RA: Benefits Persist Beyond 1 Yearѻý> Manufacturer's extension study shows no loss of clinical response Nov 06, 2020
<ѻý>Military Burn Pits Linked With RA Seropositivityѻý> Highest risks for anti-CCP antibodies seen for smokers and those with the HLA-DRB1 shared epitope genes Oct 23, 2020
<ѻý>FDA Warns Against NSAIDs in Pregnancy After 20 Weeksѻý> Risk of kidney complications and low amniotic fluids may jeopardize fetus Oct 15, 2020
<ѻý>Upadacitinib, Abatacept Go Head to Head in RAѻý> And the winner is... both, depending on whether efficacy or safety is the main criterion Oct 14, 2020
<ѻý>Depression and Biologic Use in Arthritis: Chicken or Egg?ѻý> Relationship appears to be bi-directional, researchers say Oct 02, 2020
<ѻý>Capsaicin Injection Improves Knee OA Painѻý> Investigational treatment targets capsaicin receptor to inactivate local pain fibers Sep 06, 2020
<ѻý>Joint Effusion Protective in Hand OAѻý> Unlike synovitis, which was linked with both pain and progression Sep 03, 2020
<ѻý>Al Roker's Shoulder Replacementѻý> "Today" co-host and weatherman battles osteoarthritis pain Aug 25, 2020
<ѻý>Baricitinib and Infections: What's the Risk?ѻý> Overall infections increased, but serious infections similar to placebo Aug 17, 2020
<ѻý>IL-1 Blockade: A Treatment at Last for Osteoarthritis?ѻý> Canakinumab significantly lowered the risk of joint replacements in exploratory study Aug 03, 2020
<ѻý>Tocilizumab Raises GI Risks in Rheumatoid Arthritisѻý> Double the risk of one rare but potentially deadly event compared with use of TNF inhibitors, large Swedish study found Jul 22, 2020
<ѻý>Targeting IL-23 Relieves Multiple Symptoms in PsAѻý> Both enthesitis and dactylitis improved with guselkumab treatment in psoriatic arthritis Jul 21, 2020
<ѻý>Psoriatic Arthritis: Outcomes Similar for Cosentyx and Humiraѻý> Primary endpoint of superiority for secukinumab over adalimumab not met in a phase IIIb trial Jun 08, 2020
<ѻý>Another IL-6 Blocker Succeeds in Rheumatoid Arthritisѻý> Effective in patients with moderately to severely active disease in a phase III trial Jun 03, 2020
<ѻý>EULAR 2020: What to Expectѻý> Cancelled due to pandemic but extensive menu of virtual learning planned Jun 02, 2020
<ѻý>Biologics Don't Increase Melanoma Risk... Probablyѻý> Meta-analysis offers some reassurance, but leaves room for doubt May 20, 2020
<ѻý>IL-17A Blockers Succeed in Spine Diseaseѻý> Secukinumab and ixekizumab best placebo for ankylosing spondylitis May 13, 2020
<ѻý>Study Backs Cytokine Targeting for COVID-19 Txѻý> Interrupting host inflammatory response shows promise May 08, 2020
<ѻý>Rheumatoid Arthritis: Biologic Dose Cuts Feasibleѻý> Majority of patients who achieved remission, low disease activity could lower biologic intake without flaring Apr 30, 2020
<ѻý>HCQ Plus Azithromycin: A Dangerous Combination?ѻý> Antimalarial drug appears safe alone; whether it's effective in COVID-19 still unclear Apr 14, 2020
<ѻý>Guselkumab a Hit in Phase III for PsAѻý> Primary endpoints met in two large trials in psoriatic arthritis for IL-23 inhibitor Apr 10, 2020
<ѻý>IL-17A/F Inhibitor a Winner in Spine Diseaseѻý> Targeting both cytokines had rapid, sustained benefits in ankylosing spondylitis Apr 09, 2020
<ѻý>Tanezumab: A Win as Last-Ditch Osteoarthritis Txѻý> Modest pain reduction seen in patients with no other drug options Apr 03, 2020